Galera Therapeutics Inc (GRTX)

[0210]

Close Watch: GRTX 8 x 34 + other daily technicals curling up. Now @0.14 - 0.15 > 0.1610 - 0.171(Parabolic SAR) >> 0.32, and then up to 0.50, +233% short-term target price.

[0210]

GRTX @0.14 - 0.15 fwiw.

"...risk/reward is still favorable. 28 mil cash on hand, and laying off over 70% of the workforce and stopping the 2 trials, should be ample enough money to carry them through all of 2024. Already have made it clear that they don't want to go through another trial for Avasopasem, as it is costly and time consuming, so if you are buying or going long here, you are simply playing[translation: ACCUMULATING, lol ] for one of the possible strategic maneuvers..."

Source: Click here.

[0210]

TP: 0.25 min 0.50 max and/or 0.42 ave.(short-term TP = 3x or +200% from 0.14-.0.15 current pps) .

Source: 3 stock analysts. Click here.

[glenn1919]

GRTX...................https://stockcharts.com/h-sc/ui?s=GRTX&p=W&b=5&g=0&id=p86431144783

[knrorrel]

Why ? do you think it will go higher soon ?

[Triple nickle]

Never see these prices again

[koolmc]

lol you were telling peeps to dump few days ago

[Tom turtles]

Dumped at .145..TY stock God's...In .0919

[chumfm]

Seen this many times.This goose is cooked.Expect chapter 11 in the near future.Good luck and good trading.

[Tom turtles]

You may as well unload now...geez.. what a fiasco

[Here Today]

And in the case of IPIX like it is here with Galera, the FDA constantly wants more testing and more testing. But yet for an experimental MRNA shot which scientists and the medical community will not truly know the effects for another 5 years on one’s health, they green light. In my opinion, it’s all about who greases whose palms!!!

[Here Today]

Overreaction??? This looks to be going down the route of IPIX. Both of these companies Galera and Innovation Pharma had a product for OM and both of them have been rejected by the FDA. It’s amazing to me the stupidity of how it goes especially since they have nothing that really works right now and patients that develop OM usually have to stop cancer treatments and then decide whether or not to continue once the symptoms subside and heal. And the cost for a severe OM patient to be treated is very, very expensive.

[wickerman]

$GRTX where's the guy who was pumping this trash all over iHub?
Next stop is BK and delisting.

[ATM123]

Do the company has any IP property for buyout/merger with all the trails cancellations...

[hondaboost]

Over reaction: GRTX, cash: $28.4 M. "Galera estimates that its balance of cash, cash equivalents and short-term investments as of September 30, 2023 was $28.4 million. or $0.7/share . "

[Here Today]

Not bad??? Check out market reaction. Down 50% pre market.

[sc00pnDump]

News out, need to do another phase 3 tests and submit holding back other drug to save money… not bad

[mistercellphoneman]

website is back up

[OmegaMoney29]

Wow

[ATM123]

Website is down...Whats going on

[Golden Cross]

Should be hearing something this week

[OmegaMoney29]

I bet so

[Golden Cross]

It is possible to fill that $2 gap Omega... Depends on how good the news is...

[work-n-hard]

...with Good Weather. lol

[powerbattles]

Fully loaded at an average.185

[OmegaMoney29]

Early Christmas 🎄

[work-n-hard]

Gap fill would be excellent.

[OmegaMoney29]

fda news run to $2 tomorrow??

[work-n-hard]

Yep, I think that it's leaking out that news is coming. Maybe this afternoon or tomorrow???

[Golden Cross]

Think we have seen the bottom...Looking better here

[work-n-hard]

https://www.nasdaq.com/press-release/galera-schedules-type-a-meeting-with-fda-to-discuss-next-steps-for-avasopasem-2023-09

[bluebird50]

What’s the intended date?

[powerbattles]

$GRTX According to the FDA guidance document titled “Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products Guidance for Industry”, after a Type A meeting, the FDA will provide written feedback to the sponsor or applicant within 14 calendar days of the meeting. This feedback will include a summary of the meeting, any agreements reached during the meeting, and any action items that need to be addressed by either party.

Agreements that could be reached during a Type A meeting include:

Agreement on clinical trial design: The FDA may agree to a sponsor’s or applicant’s proposed clinical trial design.

Agreement on endpoints: The FDA may agree to a sponsor’s or applicant’s proposed endpoints for a clinical trial.

Agreement on statistical analysis: The FDA may agree to a sponsor’s or applicant’s proposed statistical analysis plan for a clinical trial.

Agreement on labeling: The FDA may agree to a sponsor’s or applicant’s proposed labeling for a drug product.

[work-n-hard]

? I sent it the day before.

[Triple nickle]

Give it 10 minutes

[work-n-hard]

Sent an email to co., but no reply yet.

[sc00pnDump]

It’s not over…;)

[Golden Cross]

Should have known when the posting stopped by a few people that they sold and it was over

[Golden Cross]

Yep between the company selling shares and shorts u can't win with BIO's... just be ready to sell the spikes and i fucked up yesterday early... about all gone now...

[work-n-hard]

...or the result of complete silence.

[frans]

we see an sell off here ??????time will tell

[Golden Cross]

Criminal activity on the Ask

[work-n-hard]

GRTX: Personally, I think there is just a lot of folks holding and are in a waiting pattern. Unfortunately, that allows the shorts to do their thing and keep it down and take it lower.
The flip side of that is, with the right pressure, they'll be the ones Buying, just to stop the bleeding.
This week brings the 30days to an end.
Holding and added some this morning from INVO profits.
(I'm not one for "averaging down", just adding and as luck would have it, the price is lower than I started in at.)

[GeorgeTheStub]

surprising that GRTX trading red.

[work-n-hard]

GRTX: over $600G's in 90 mins of trading.

[Golden Cross]

$GRTX FDA News Any time Now

[Golden Cross]

Large early volume today

[work-n-hard]

FWIW: CLick the date and look at the embedded post and note the number of Followers.

New high of day

We are in at .17

Congrats team.$GRTX was easy money ❤️👨🏽‍🍳💰🤯👉🏽📈 https://t.co/DSbWDZo52N

— Stock PlayMaker 🌐 (@stockplaymaker1) October 18, 2023

[work-n-hard]

GRTX: The FDA is expected to issue written meeting minutes approximately 30 days following the meeting.

https://www.nasdaq.com/press-release/galera-schedules-type-a-meeting-with-fda-to-discuss-next-steps-for-avasopasem-2023-09

[work-n-hard]

GRTX: Should not be any dilution for a while. >>>>>>>>>

As of June 30, 2023, Galera had cash, cash equivalents and short-term investments of $38.8 million. Galera expects that its existing cash, cash equivalents and short-term investments, taking into account the implementation of the reduction in workforce announced in August 2023, will enable Galera to fund its operating expenses and capital expenditure requirements into the second quarter of 2024.

https://www.nasdaq.com/press-release/galera-reports-second-quarter-2023-financial-results-and-recent-corporate-updates